Lithium causes diabetes insipidus by interfering with the kidney’s ability to respond to antidiuretic hormone, the signal that tells your kidneys to concentrate urine and hold onto water. Between 50% and 73% of long-term lithium users develop some degree of this condition, called nephrogenic diabetes insipidus (NDI). The result is that your kidneys produce large volumes of dilute urine even when your body is dehydrated.
How Lithium Gets Into Kidney Cells
The process starts with lithium hitching a ride into the wrong cells. In the collecting ducts of your kidneys, where final water reabsorption happens, the cells lining the duct have sodium channels on their surface. Lithium ions are small enough to slip through these same channels, called epithelial sodium channels (ENaC). Once inside the principal cells of the collecting duct, lithium begins disrupting the molecular machinery those cells need to pull water back from urine into the bloodstream.
The Water Channel Problem
Your kidneys concentrate urine using water channels called aquaporin-2 (AQP2). Normally, when you’re dehydrated, your brain releases antidiuretic hormone. That hormone binds to receptors on collecting duct cells, triggering a chain reaction: the cells produce a signaling molecule called cyclic AMP (cAMP), which causes AQP2 water channels to move to the cell surface. Once in place, these channels let water flow out of the forming urine and back into your blood.
Lithium disrupts this process at multiple levels. In the short term, it blocks cAMP production, which means the water channels never get the signal to move to the cell surface. Without those channels in position, water stays in the urine instead of being reabsorbed. Over longer periods of treatment, lithium goes further and reduces the total amount of AQP2 protein the cells produce. So even if the signaling pathway were restored, there are fewer water channels available to do the job.
Lithium also interferes with a urea transporter (UT-A1) that helps maintain the concentration gradient in the inner part of the kidney. This gradient is what draws water out of the collecting duct in the first place. When both the water channels and the concentration gradient are impaired, the kidney loses its ability to make concentrated urine.
Multiple Pathways, Not Just One
Researchers have identified several mechanisms working in parallel. One involves an enzyme called GSK3-beta. Lithium inhibits this enzyme, and studies using other GSK3-beta inhibitors show a similar drop in AQP2 levels, confirming that this pathway contributes to the problem. Mice genetically engineered to lack GSK3-beta specifically in their collecting ducts showed mild symptoms under normal conditions but couldn’t concentrate urine properly when dehydrated or stimulated with antidiuretic hormone. This suggests GSK3-beta plays a particularly important role when the body is under water stress.
Interestingly, lithium and dedicated GSK3-beta inhibitors appear to reduce AQP2 through different downstream mechanisms, meaning lithium attacks water channel production from more than one angle. Another contributing pathway involves prostaglandin E2, an inflammatory signaling molecule. Lithium increases its production in the kidney, and it activates a receptor that further suppresses AQP2. A protein kinase called PKC-alpha also plays a role by triggering the removal of AQP2 channels from the cell surface, essentially pulling the channels back inside the cell even if they managed to get into position.
What It Feels Like
The hallmark symptoms are excessive thirst and large volumes of dilute urine, sometimes several liters per day. You may find yourself waking multiple times at night to urinate. The urine is pale and watery because the kidneys can’t concentrate it. In diagnostic terms, urine concentration drops below 300 mOsm/kg (normal concentrated urine is significantly higher), and a water deprivation test shows the kidneys fail to concentrate urine even after hours without drinking. The key distinction from other forms of diabetes insipidus is that giving synthetic antidiuretic hormone produces less than a 10% improvement, confirming the kidneys themselves aren’t responding to the hormone rather than there being a shortage of it.
Is It Reversible?
For many people, the condition improves after stopping lithium. Polyuria (excessive urination) often resolves within a few weeks of discontinuation, though full restoration of concentrating ability can take several months. However, this isn’t guaranteed. In patients who have taken lithium for many years, the collecting duct cells can sustain structural damage, including scarring of the tissue between the kidney tubules. There are documented cases of NDI persisting years after stopping lithium, including one case lasting 57 months. The longer someone has been on lithium and the more severe the concentrating defect, the less likely it is to fully reverse.
This is why early detection matters. Guidelines recommend testing kidney concentrating ability and measuring urine volume before starting lithium, then repeating these checks annually. Blood levels of lithium and creatinine (a marker of overall kidney function) should be checked every two to six months. Using the lowest effective lithium dose and once-daily dosing schedules may reduce the risk.
How It’s Managed
If lithium remains necessary for psychiatric treatment, the most common intervention is amiloride, a medication that blocks the same sodium channels lithium uses to enter collecting duct cells. By closing off lithium’s entry point, amiloride reduces the amount of lithium accumulating inside the cells that control water reabsorption. This doesn’t interfere with lithium’s therapeutic blood levels for mood stabilization, but it limits the local damage in the kidney.
Adequate hydration is essential. Because the kidneys can’t conserve water properly, dehydration develops quickly if fluid intake doesn’t keep pace with urine output. This becomes particularly dangerous during illness, hot weather, or any situation where access to water is limited. The combination of high urine output and restricted fluid intake can lead to dangerous elevations in blood sodium levels.